The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs
dc.conference.date | SEP 16-21, 2021 | |
dc.conference.title | Congress of the European-Society-for-Medical-Oncology (ESMO) | |
dc.contributor.author | Garcia-Carbonero, R. | |
dc.contributor.author | Benavent, M. | |
dc.contributor.author | Fonseca, P. Jimenez | |
dc.contributor.author | Castellano, D. | |
dc.contributor.author | Alonso-Gordoa, T. | |
dc.contributor.author | Teule, A. | |
dc.contributor.author | Custodio, A. | |
dc.contributor.author | Tafuto, S. | |
dc.contributor.author | La Casta, A. | |
dc.contributor.author | Spada, F. | |
dc.contributor.author | Lopez, C. | |
dc.contributor.author | Ibrahim, T. | |
dc.contributor.author | Silva, M. J. Villanueva | |
dc.contributor.author | Iranzo, V. | |
dc.contributor.author | Garcia-Alfonso, P. | |
dc.contributor.author | Gonzalez-Flores, E. | |
dc.contributor.author | Grande, E. | |
dc.contributor.author | Crespo, G. | |
dc.contributor.author | Carmona-Bayonas, A. | |
dc.contributor.author | Capdevila, J. | |
dc.contributor.authoraffiliation | [Garcia-Carbonero, R.] Univ Hosp 12 Octubre, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Benavent, M.] Hosp Virgen Rocio, Dept Med Oncol, Seville, Spain | |
dc.contributor.authoraffiliation | [Fonseca, P. Jimenez] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain | |
dc.contributor.authoraffiliation | [Castellano, D.] Hosp Univ 12 Octubre, Med Oncol Dept, Imas 12, Madrid, Spain | |
dc.contributor.authoraffiliation | [Alonso-Gordoa, T.] Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Teule, A.] Inst Catala Oncol Lhospitalet, Med Oncol, Lhospitalet De Llobregat, Spain | |
dc.contributor.authoraffiliation | [Custodio, A.] Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Tafuto, S.] Ist Nazl Tumori Fdn Pascale Napoli, Med Oncol Dept, Naples, Italy | |
dc.contributor.authoraffiliation | [La Casta, A.] Hosp Univ Donostia, Med Oncol Dept, San Sebastian, Spain | |
dc.contributor.authoraffiliation | [Spada, F.] Ist Europeo Oncol, Med Oncol, Milan, Italy | |
dc.contributor.authoraffiliation | [Lopez, C.] Hosp Univ Marques Valdecilla, IDIVAL, Med Oncol Dept, Santander, Spain | |
dc.contributor.authoraffiliation | [Ibrahim, T.] Ist Tumori Romagna IRST, Tumori Rari & Testacollo Dept, Meldola, Italy | |
dc.contributor.authoraffiliation | [Silva, M. J. Villanueva] Hosp Alvaro Cunqueiro, Med Oncol, Vigo, Spain | |
dc.contributor.authoraffiliation | [Iranzo, V.] Hosp Gen Univ Valencia, Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Garcia-Alfonso, P.] Hosp Univ Gregorio Maranon, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Gonzalez-Flores, E.] Hosp Univ Virgen Las Nieves, Med Oncol, Granada, Spain | |
dc.contributor.authoraffiliation | [Grande, E.] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Crespo, G.] Hosp Univ Burgos, Dept Med Oncol, Burgos, Spain | |
dc.contributor.authoraffiliation | [Carmona-Bayonas, A.] Hosp Univ Morales Meseguer, Med Oncol, Murcia, Spain | |
dc.contributor.authoraffiliation | [Capdevila, J.] Vall Hebron Univ Hosp, Gastrointestinal & Endocrine Tumor Dept, Inst Oncol, Barcelona, Spain | |
dc.contributor.funder | Pfizer | |
dc.date.accessioned | 2025-01-07T14:33:41Z | |
dc.date.available | 2025-01-07T14:33:41Z | |
dc.date.issued | 2021-09-21 | |
dc.identifier.doi | 10.1016/j.annonc.2021.08.179 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.annonc.2021.08.179 | |
dc.identifier.uri | https://hdl.handle.net/10668/26495 | |
dc.identifier.wosID | 700527702115 | |
dc.issue.number | 5 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen de las Nieves | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.page.number | S907-S908 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 32 | |
dc.wostype | Meeting Abstract |